Transforming
Lifesciences with
Artificial Intelligence

A leading international MedTech company aimed to improve market visibility and strategic decision-making. Vamstar implemented an AI-powered data orchestration engine, providing comprehensive analysis of tender data and market insights. This transformation enhanced the client’s understanding of market trends and enabled targeted strategies for product introduction and competitive differentiation. Key outcomes included a 4.5% improvement in margins and a 9.2% increase in revenues, demonstrating the significant impact of AI in driving growth and profitability in the MedTech sector.

MedTech Europe engaged Vamstar to conduct a thorough examination of ESG criteria adoption within European MedTech tenders. Leveraging advanced natural language processing and machine learning technologies, Vamstar analyzed over 15,000 tender documents. This comprehensive study provided insights into the increasing importance of ESG factors, identifying growth in ESG weightage from less than 5% in 2020 to 7.3% in 2022, and highlighting best practices that foster effective ESG integration. The analysis also delved into the specific language used in tenders to articulate ESG expectations, offering strategic guidance for enhancing sustainability in procurement processes.

Discover how Vamstar empowered a leading pharmaceutical company to optimize post-LoE market strategies using AI-driven insights, boosting competitiveness, profitability, and long-term positioning.

In the fiercely competitive biosimilars market, two prominent pharmaceutical companies were navigating the complexities of multi-asset licensing arrangements and needed to reevaluate investment strategies. 

A global manufacturer of medical devices and consumables needed to evaluate how emerging ESG (Environmental, Social, and Governance) requirements would impact product marketability across the EU4, UK, and Nordics. Seeking to better understand market risks and opportunities, the client approached Vamstar for insights into differentiation strategies to expand market share.

A leading pharmaceutical company with a robust international presence and growing operations in Europe found itself grappling with increased competition in the generics market, particularly in tenders following Loss of Exclusivity (LoE), where market prices plummeted by up to 95%.

A global pharmaceutical leader collaborated with Vamstar to address complex pricing challenges impacting key assets amidst rising biosimilar competition. The client aimed to capture current net prices across critical markets and forecast trends over a 3 to 5-year horizon. Leveraging Vamstar’s AI-powered net price tracker, list-to-net effect modeling, and machine learning forecasting capabilities, the project encompassed an extensive collection of historical data from 15 countries and predictive analysis based on over 300 variables.By integrating these data points with market indicators and employing reinforcement learning for adaptive insights, Vamstar enabled the client to simulate price evolutions and identify regional discounting patterns. This strategic approach provided clarity in gross-to-net pricing and supported confident, data-backed decision-making in future product lifecycle management and pricing strategies.

Discover how a leading healthcare company leveraged Vamstar’s AI-driven market intelligence to streamline acquisition targeting, segment niche markets, and assess revenue forecasts—driving successful strategic investments in the MedTech sector.

Overcome Global Market Challenges through Data-Driven Strategies.